Loading...
XWAR
ADV
Market cap1mUSD
Jul 09, Last price  
0.43PLN
1D
-3.80%
1Q
-28.33%
Jan 2017
-98.46%
IPO
-98.45%
Name

Adiuvo Investments SA

Chart & Performance

D1W1MN
XWAR:ADV chart
P/E
P/S
6.98
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-2.93%
Revenues
812k
+143.11%
036,0003,937,0004,779,0005,762,0002,794,0001,778,000942,0001,604,000173,000990,000334,000812,000
Net income
-2m
L-43.65%
-3,143,3351,723,000-17,964,000-17,196,000-52,562,000-27,208,000-17,212,000-13,009,000-17,338,000-57,896,000-10,840,000-2,788,000-1,571,000
CFO
-376k
L-89.00%
-3,604,002-8,904,000-17,997,000-20,270,000-32,330,000-14,562,000-4,306,000-9,358,000-5,777,000-7,615,000-4,980,000-3,417,000-376,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Adiuvo Investments S.A. operates as a venture capital firm, deploying capital across the entire spectrum of business development, from initial incubation and seed funding to supporting early-stage, startup, and growth-phase companies. Its primary investment focus lies in the medical devices, digital health, and nutraceuticals sectors, specifically targeting opportunities within Poland. The firm typically commits up to €3 million (approximately $3.35 million) per venture, with an intended holding period of three to five years. All investments are made directly from Adiuvo's own balance sheet. Established in 2013, the company maintains its headquarters in Warsaw, Poland.
IPO date
May 27, 2015
Employees
8
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT